CHICAGO -- For the first time in a multicenter randomized trial, minimally invasive glaucoma surgery (MIGS) with an intracanalicular (Schlemm's canal) stent significantly reduced long-term vision loss ...
Glaukos secured a new FDA clearance for its miniaturized stent system designed for glaucoma to help drain the inner eye of built-up fluids and normalize intraocular pressure. The company had received ...
Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with glaucoma, expanding the company’s reach overseas. The green lights under ...
SLT is emerging as a cost-effective first-line treatment, offering superior intraocular pressure stability compared to traditional eye drops. Minimally invasive glaucoma surgeries, like the iStent ...
The Food and Drug Administration recently approved the CyPass Micro-Stent for the treatment of glaucoma. The stent, produced by Fort Worth, Texas-based Alcon, is a micro-invasive surgical device used ...
Worldwide, more than one million trabecular microbypass stents have been implanted in combination with cataract surgery. Despite glaucoma medications and prior microbypass stenting, target IOP may no ...
The Northwestern University Center for Engineering in Vision and Ophthalmology (CEVO) connects engineering innovations with clinical needs in ophthalmology by developing, translating, and sharing new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results